Hospira Tells Fed. Circ. To Reverse Sedative Patent Loss
Hospira Inc. asked the Federal Circuit on Tuesday to uphold the validity of a patent for its sedation drug Precedex for the second time this year, arguing that an Illinois federal...To view the full article, register now.
Already a subscriber? Click here to view full article